MedPath

SHR2285

Generic Name
SHR2285

A Trial of SHR2285 in Healthy Subjects

Phase 1
Completed
Conditions
Healthy Volunteers
Interventions
First Posted Date
2021-04-02
Last Posted Date
2022-03-08
Lead Sponsor
Atridia Pty Ltd.
Target Recruit Count
31
Registration Number
NCT04829305
Locations
🇦🇺

Linear Clinical research, Perth, Western Australia, Australia

The PK/PD Study of SHR2285 Tablets in Healthy Subjects

Phase 1
Completed
Conditions
Thrombosis
Interventions
Drug: Placebo
First Posted Date
2018-12-10
Last Posted Date
2021-05-24
Lead Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Target Recruit Count
28
Registration Number
NCT03769831
Locations
🇨🇳

Peking Union Medical College Hospital, Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath